| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 22 Apr 2024 | 9 Apr 2024 |
| Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/04/2024 inter alia to consider and approve Audited Financial Results for the quarter and year ended on 31.03.2024 and recommendation of Final Dividend if any. Outcome of Board Meeting held on Monday, 22nd April, 2024 Audited Financial Results for the quarter and year ended on 31.03.2024. (As Per BSE Announcement Dated on 22.04.2024) | ||
| Board Meeting | 24 Jan 2024 | 2 Jan 2024 |
| Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve Un-Audited Financial Results of the Company for the Third Quarter and Nine Months ended on 31st December 2023. Epigral Limited (formerly known as Meghmani Finechem Limited) submits the Unaudited Financial Results for the Third Quarter and Nine months ended on 31st December, 2023. Epigral Limited (formerly known as Meghmani Finechem Limited) submits the Unaudited Financial Results for the Third Quarter and Nine months ended on 31st December, 2023. (As Per BSE Announcement Dated on 24/01/2024) | ||
| Board Meeting | 6 Nov 2023 | 11 Oct 2023 |
| Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Un-Audited Financial Results for second quarter and half year ended 30th September 2023. Outcome of Board Meeting held on 06th November, 2023 and submission of Un-Audited Financial Results (Standalone & Consolidated) for Second Quarter and Half Year ended on 30th September, 2023. Outcome of the Board Meeting held on Monday, 6th November, 2023 and submission of Un-Audited Financial Results (Standalone & Consolidated) for second quarter and half year ended 30th September, 2023. (As Per BSE Announcement Dated on 06/11/2023) Epigral Limited (formerly known as Meghmani Finechem Limited) submits newspaper publication of Un-audited Financial Results for second quarter and half year ended 30.09.2023 published in Financial Express (English & Gujarati) on 07.11.2023. (As Per BSE Announcement Dated on 07/11/2023) | ||
| Board Meeting | 5 Aug 2023 | 28 Jul 2023 |
| Meghmani Finechem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 inter alia to consider and approve Unaudited Financial Results for the quarter ended on 30.06.2023. Epigral Limited (Formerly known as Meghmani Finechem Limited) submits the Unaudited Financial Results for the quarter ended on 30th June, 2023. Epigral Limited (Formerly known as Meghmani Finechem Limited) submits the Outcome of Board Meeting held on 05.08.2023. Epigral Limited (Formerly known as Meghmani Finechem Limited) intimate for Change in Designation of the Directors. (As Per BSE Announcement Dated on 05.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
